Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05400980 · ClinicalTrials.gov registry record · NA

Expander-2 Trial: Randomized Study to Evaluate Safety & Efficacy of the Urocross® Expander System & Retrieval Sheath

A NA study of Benign Prostatic Hyperplasia, sponsored by Prodeon Medical.

Active
Registry status
NA
Development phase
240
Enrollment target
2
Study locations

NCT05400980 is a NA study of Benign Prostatic Hyperplasia that is active but no longer recruiting, run by Prodeon Medical. The registered enrollment target is 240 participants, below the 544-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (56% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05400980, a NA study of Benign Prostatic Hyperplasia, is active but no longer recruiting, sponsored by Prodeon Medical.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
240 participants
Enrollment target
2
Study locations

Study Summary

To demonstrate the safety and efficacy of the Urocross Expander System/Retrieval Sheath and the procedure to treat patients with symptomatic Benign Prostatic Hyperplasia (BPH).

Conditions Studied

Benign Prostatic Hyperplasia

Interventions

  • DEVICE Urocross implant
  • DIAGNOSTIC_TEST Sham-control

Study Locations (2)

Illinois

  • Loyola University Medical Center - Maywood

Virginia

  • Virginia Tech-Carilion School of Medicine - Roanoke

Trial Details

FieldValue
Enrollment Target 240 participants
Start Date 2022-07-05
Est. Completion 2028-12
Phase NA

Sponsor

Prodeon Medical

1 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05400980

The ClinicalTrials.gov registry entry for NCT05400980 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 240 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 544-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (56% lower). The listed sponsor is Prodeon Medical, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Benign Prostatic Hyperplasia appearing as the primary indexed condition, and to 2 interventions - of which Urocross implant is the first listed.

NCT05400980 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Virginia.

Frequently Asked Questions

What is clinical trial NCT05400980 about?

NCT05400980 is a clinical study titled "Expander-2 Trial: Randomized Study to Evaluate Safety & Efficacy of the Urocross® Expander System & Retrieval Sheath". To demonstrate the safety and efficacy of the Urocross Expander System/Retrieval Sheath and the procedure to treat patients with symptomatic Benign Prostatic Hyperplasia (BPH).

What is the current status of trial NCT05400980?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 240 participants. The study started on 2022-07-05. Estimated completion is 2028-12.

What conditions does trial NCT05400980 study?

This clinical trial studies the following conditions: Benign Prostatic Hyperplasia.

What interventions are being tested in trial NCT05400980?

The interventions under investigation include: Urocross implant (DEVICE), Sham-control (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT05400980?

This trial is sponsored by Prodeon Medical, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05400980 being conducted?

This trial has 2 study locations across Illinois, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Benign Prostatic Hyperplasia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Benign Prostatic Hyperplasia

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.